Brazilian: cost-cuts promise more cash for medical technology
This article was originally published in Clinica
The significant savings that should result from a Brazilian initiative to rationalise the purchasing of high-cost medicines will be invested in increasing access to certain medical procedures and basic healthcare products. So said the health ministry of an e-tendering and price-referencing register for so-called "exceptional medicines", launched at the end of November. The programme is expected to halve the cost of some of these medicines, which make up a market worth R$1.2bn (US$540m).